UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.661

Sortiert nach

Outcomes of extracorporeal photopheresis in a diverse cohort of patients with cutaneous T-cell lymphoma: a retrospective study at a tertiary care hospital

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2312250-2312250

2024

Volltextzugriff (PDF)

Dr. Madeleine Duvic: Profiling women dermatologists’ contributions to HIV research and treatment

International journal of women's dermatology, 2022-10, Vol.8 (3), p.e019-e019

2022

Volltextzugriff (PDF)

Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study

Journal of hematology and oncology, 2022-07, Vol.15 (1), p.96-96, Article 96

2022

Volltextzugriff (PDF)

The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches

Journal of the American Academy of Dermatology, 2021-03, Vol.84 (3), p.597-604

2021

Volltextzugriff (PDF)

RNA Editing Induces Variation in Desensitization and Trafficking of 5-Hydroxytryptamine 2c Receptor Isoforms

The Journal of biological chemistry, 2004-01, Vol.279 (4), p.2945-2954

2004

Volltextzugriff (PDF)

The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication

Journal of the American Academy of Dermatology, 2021-03, Vol.84 (3), p.587-595

2021

Volltextzugriff (PDF)

Silicone injection-induced granuloma formation, hypercalcemia and nephrolithiasis: a case report

Urology case reports, 2021-05, Vol.36, p.101563, Article 101563

2021

Volltextzugriff (PDF)

Cutaneous T-cell Lymphoma

Hematology/oncology clinics of North America, 2024-07

2024

Volltextzugriff (PDF)

Evidence for a Model of Agonist-induced Activation of 5-Hydroxytryptamine 2A Serotonin Receptors That Involves the Disruption of a Strong Ionic Interaction between Helices 3 and 6

The Journal of biological chemistry, 2002-03, Vol.277 (13), p.11441-11449

2002

Volltextzugriff (PDF)

Validating the optimal classification approach using International Classification of Diseases, 10th Revision codes to identify dermatology patients with acne

Journal of the American Academy of Dermatology, 2021-05, Vol.84 (5), p.1491-1493

2021

Volltextzugriff (PDF)

Priorities in Parkinson's disease research

Nature reviews. Drug discovery, 2011-05, Vol.10 (5), p.377-393

2011

Volltextzugriff (PDF)

Acne and antibiotics: a look back

International journal of dermatology, 2021-08, Vol.60 (8), p.1019-1027

2021

Volltextzugriff (PDF)

Functional enhancement of AT1R potency in the presence of the TPαR is revealed by a comprehensive 7TM receptor co-expression screen

PloS one, 2013-03, Vol.8 (3), p.e58890-e58890

2013

Volltextzugriff (PDF)

Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas

Journal of the American Academy of Dermatology, 2021-01, Vol.84 (1), p.196-198

2021

Volltextzugriff (PDF)

A Novel Risk Prediction Model to Triage Difficult Urethral Catheterizations

Urology (Ridgewood, N.J.), 2021-11, Vol.157, p.35-40

2021

Volltextzugriff (PDF)

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day

Schizophrenia research, 2012-11, Vol.141 (2), p.144-152

2012

Volltextzugriff (PDF)

The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic Hematuria

Urology (Ridgewood, N.J.), 2019-04, Vol.126, p.34-38

2019

Volltextzugriff (PDF)

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day

Schizophrenia research, 2012-11, Vol.141 (2-3), p.144-152

2012

Volltextzugriff (PDF)

A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein

Journal of Parkinson's disease, 2019-01, Vol.9 (1), p.31

2019

Volltextzugriff (PDF)

Impact of an Acute Care Urology Service on Timelines and Quality of Care in the Management of Nephrolithiasis

Journal of endourology, 2022-03, Vol.36 (3), p.351

2022

Volltextzugriff (PDF)

Usage and safety of topical tacrolimus in patients with mycosis fungoides

Clinical and experimental dermatology, 2022-06, Vol.47 (6), p.1200-1201

2022

Volltextzugriff (PDF)

Management of relapsed cutaneous T‐Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case

Dermatologic therapy, 2022-07, Vol.35 (7), p.e15538-n/a

2022

Volltextzugriff (PDF)

Pharmacology of N-desmethylclozapine

Pharmacology & therapeutics (Oxford), 2007-08, Vol.115 (2), p.223-231

2007

Volltextzugriff (PDF)

A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model

Pharmacology, biochemistry and behavior, 2008-10, Vol.90 (4), p.540-544

2008

Volltextzugriff (PDF)

Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers

Sleep medicine, 2011-02, Vol.12 (2), p.134-141

2011

Volltextzugriff (PDF)

1 – 25 von 1.661

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.529)
Mit Volltextzugriff
(1.390)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.159)
Life Sciences & Biomedicine
(1.000)
Humans
(823)
Female
(455)
Male
(413)
Biological And Medical Sciences
(337)
Animals
(322)
Medical Sciences
(245)
Middle Aged
(234)
Aged
(221)
Adult
(204)
Neurosciences & Neurology
(195)
Mice
(163)
Immunology
(144)
Clinical Neurology
(141)
Neurology
(138)
Biochemistry & Molecular Biology
(118)
Fundamental And Applied Biological Sciences. Psychology
(115)
Adolescent
(97)
Medicine, Research & Experimental
(96)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Outcomes of extracorporeal photopheresis in a diverse cohort of patients with cutaneous T-cell lymphoma: a retrospective study at a tertiary care hospital

Dr. Madeleine Duvic: Profiling women dermatologists’ contributions to HIV research and treatment

Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study

The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches

RNA Editing Induces Variation in Desensitization and Trafficking of 5-Hydroxytryptamine 2c Receptor Isoforms

The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication

Silicone injection-induced granuloma formation, hypercalcemia and nephrolithiasis: a case report

Cutaneous T-cell Lymphoma

Evidence for a Model of Agonist-induced Activation of 5-Hydroxytryptamine 2A Serotonin Receptors That Involves the Disruption of a Strong Ionic Interaction between Helices 3 and 6

Validating the optimal classification approach using International Classification of Diseases, 10th Revision codes to identify dermatology patients with acne

Priorities in Parkinson's disease research

Acne and antibiotics: a look back

Functional enhancement of AT1R potency in the presence of the TPαR is revealed by a comprehensive 7TM receptor co-expression screen

Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas

A Novel Risk Prediction Model to Triage Difficult Urethral Catheterizations

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day

The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic Hematuria

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day

A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein

Impact of an Acute Care Urology Service on Timelines and Quality of Care in the Management of Nephrolithiasis

Usage and safety of topical tacrolimus in patients with mycosis fungoides

Management of relapsed cutaneous T‐Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case

Pharmacology of N-desmethylclozapine

A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model

Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers

Suchergebnisse filtern